KIF14 and urinary bladder cancer: Mechanistically, miR-152-3p directly targets KIF14, leading to a reduction in its expression, which in turn inhibits the PI3K/AKT and FOXM1/CCNB1 pathways, thereby impeding the progression of bladder cancer.